PATENT CLAIM ANALYSIS

Application Number: 16026319
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-06
Patent Classification: ["514", "008600"]

Abstract:
Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.

Claim (Index 31):
The method of  claim 30 , wherein the human serum albumin or variant thereof has an amino acid sequence set forth in any one of SEQ ID NOs: 54-56, or 124.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 95.0
- Lexical Diversity: 1.2963
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15281795', '15618478', '14967980', '13068808', '14187728']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7639182027921524
- 35 USC 102 Novelty (BERT): 0.6952870686867796
- Combined Prediction Score: 0.7570550893816151
- Mean Citation Score: 464.04995
- Max Citation Score: 816.3939999999999
- Similarity Product: 673.0385775067805

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test